BioGend Therapeutics Co., Ltd. (TPEX:6733)
Taiwan · Delayed Price · Currency is TWD 26.25
-2.65 (-9.17%)
Jul 30, 2026, 12:46 PM CST
BioGend Therapeutics Market Cap
BioGend Therapeutics has a market cap or net worth of 3.59 billion as of July 29, 2026. Its market cap has decreased by -1.29% in one year.
Market Cap
3.59B
Enterprise Value
2.75B
Revenue
229.81M
Ranking
n/a
PE Ratio
n/a
Stock Price
26.25
ChartMarket Cap Chart
Since June 18, 2019, BioGend Therapeutics's market cap has increased from 2.71B to 3.59B, an increase of 32.41%. That is a compound annual growth rate of 4.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 3.59B | -24.74% |
| Dec 31, 2025 | 4.78B | 14.21% |
| Dec 31, 2024 | 4.18B | -11.18% |
| Dec 29, 2023 | 4.71B | 109.50% |
| Dec 30, 2022 | 2.25B | -18.50% |
| Dec 30, 2021 | 2.76B | -22.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Formosa Pharmaceuticals | 3.67B |
| Genovate Biotechnology | 3.65B |
| OBI Pharma | 3.57B |
| Senhwa Biosciences | 3.52B |
| Sagittarius Life Science | 3.36B |
| SYN-TECH Chem. & Pharm. | 3.20B |
| Apex Biotechnology | 3.17B |
| Shine-On BioMedical | 3.14B |